OCUL vs PG · rev $63.7M vs P/E 25, rev $84.28B
Ocular Therapeutix Inc (OCUL) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported OCUL revenue for 2024-12-31 was $63.7M. Net income was -$193.5M. Revenue was up 9.0% from 2023-12-31 to 2024-12-31. OCUL currently screens at market cap $1.76B.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
OCUL currently screens at market cap $1.76B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the OCUL and PG stock pages for the full models.
Not investment advice.